Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study.
Bettiol A, Urban ML, Dagna L, Cottin V, Franceschini F, Del Giacco S, Schiavon F, Neumann T, Lopalco G, Novikov P, Baldini C, Lombardi C, Berti A, Alberici F, Folci M, Negrini S, Sinico RA, Quartuccio L, Lunardi C, Parronchi P, Moosig F, Espígol-Frigolé G, Schroeder J, Kernder AL, Monti S, Silvagni E, Crimi C, Cinetto F, Fraticelli P, Roccatello D, Vacca A, Mohammad AJ, Hellmich B, Samson M, Bargagli E, Cohen Tervaert JW, Ribi C, Fiori D, Bello F, Fagni F, Moroni L, Ramirez GA, Nasser M, Marvisi C, Toniati P, Firinu D, Padoan R, Egan A, Seeliger B, Iannone F, Salvarani C, Jayne D, Prisco D, Vaglio A, Emmi G; European EGPA Study Group. Bettiol A, et al. Among authors: ribi c. Arthritis Rheumatol. 2022 Feb;74(2):295-306. doi: 10.1002/art.41943. Epub 2021 Dec 30. Arthritis Rheumatol. 2022. PMID: 34347947 Free PMC article.
Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors: A prospective randomized study of one hundred twenty-four patients.
Ribi C, Cohen P, Pagnoux C, Mahr A, Arène JP, Puéchal X, Carli P, Kyndt X, Le Hello C, Letellier P, Cordier JF, Guillevin L; French Vasculitis Study Group. Ribi C, et al. Arthritis Rheum. 2010 Apr;62(4):1186-97. doi: 10.1002/art.27340. Arthritis Rheum. 2010. PMID: 20131268 Free article. Clinical Trial.
Long-term follow-up of a randomized trial on 118 patients with polyarteritis nodosa or microscopic polyangiitis without poor-prognosis factors.
Samson M, Puéchal X, Devilliers H, Ribi C, Cohen P, Bienvenu B, Ruivard M, Terrier B, Pagnoux C, Mouthon L, Guillevin L; French Vasculitis Study Group (FVSG). Samson M, et al. Among authors: ribi c. Autoimmun Rev. 2014 Feb;13(2):197-205. doi: 10.1016/j.autrev.2013.10.001. Epub 2013 Oct 23. Autoimmun Rev. 2014. PMID: 24161361
Mononeuritis multiplex predicts the need for immunosuppressive or immunomodulatory drugs for EGPA, PAN and MPA patients without poor-prognosis factors.
Samson M, Puéchal X, Devilliers H, Ribi C, Cohen P, Bienvenu B, Terrier B, Pagnoux C, Mouthon L, Guillevin L; French Vasculitis Study Group (FVSG). Samson M, et al. Among authors: ribi c. Autoimmun Rev. 2014 Sep;13(9):945-53. doi: 10.1016/j.autrev.2014.08.002. Epub 2014 Aug 19. Autoimmun Rev. 2014. PMID: 25153486 Clinical Trial.
[Allergy to human seminal plasma].
Moi L, Salvadé I, Ribi C. Moi L, et al. Among authors: ribi c. Rev Med Suisse. 2017 Apr 5;13(557):748-753. Rev Med Suisse. 2017. PMID: 28722364 French.
[Seasonal allergic rhinitis].
Salvadé I, Moi L, Ribi C, Spertini F. Salvadé I, et al. Among authors: ribi c. Rev Med Suisse. 2018 Apr 4;14(601):726-730. Rev Med Suisse. 2018. PMID: 29620294 French.
Risk of malignancy in patients treated for systemic necrotising vasculitis.
Lafarge A, Joseph A, Pagnoux C, Puechal X, Cohen P, Samson M, Hamidou M, Karras A, Groh M, Quemeneur T, Ribi C, Mouthon L, Guillevin L, Terrier B; French Vasculitis Study Group (FVSG). Lafarge A, et al. Among authors: ribi c. Ann Rheum Dis. 2020 Mar;79(3):431-433. doi: 10.1136/annrheumdis-2019-216452. Epub 2019 Nov 25. Ann Rheum Dis. 2020. PMID: 31767700 No abstract available.
Predictive factors of severe infections in patients with systemic necrotizing vasculitides: data from 733 patients enrolled in five randomized controlled trials of the French Vasculitis Study Group.
Lafarge A, Joseph A, Pagnoux C, Puéchal X, Cohen P, Samson M, Hamidou M, Karras A, Quemeneur T, Ribi C, Groh M, Mouthon L, Guillevin L, Terrier B; French Vasculitis Study Group (FVSG). Lafarge A, et al. Among authors: ribi c. Rheumatology (Oxford). 2020 Sep 1;59(9):2250-2257. doi: 10.1093/rheumatology/kez575. Rheumatology (Oxford). 2020. PMID: 31782786
145 results